https://www.agastiyabiotech.com/wp-content/uploads/2020/04/covid19-2.jpeg
Recent Posts
- Vopec Pharmaceuticals and Agastiya Biotech Announce Breakthrough Phase 1 Study Results of Small Molecule AB001 for Multiple Metastatic Solid Tumors
- Agastiya Biotech receives FDA Orphan Drug Designation for AB001 for Pancreatic cancer and Acute Myeloid Leukemia (AML)
- Introducing Quantum Medicine to the World
- Agastiya Biotech Proceeding with Drug Candidate for COVID-19: Small Molecule Compound for Treatment of SARS-CoV-2
- Vopec gets NOC & test license from DCGI to develop new cancer drug that offers therapeutic option for COVID-19

Recent Comments